The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.

House, Rachel; Kritikos, Vicky; Cvetkovski, Biljana; Rimmer, Janet; Yan, Kwok; Cheong, Lynn; Bousquet, Jean; Lourenco, Olga; Bosnic-Anticevich, Sinthia

House, Rachel; Kritikos, Vicky; Cvetkovski, Biljana; Rimmer, Janet; Yan, Kwok; Cheong, Lynn; Bousquet, Jean; Lourenco, Olga; Bosnic-Anticevich, Sinthia.

Afiliação

House R; Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Glebe, NSW, Australia.
Kritikos V; Macquarie University, Macquarie Park, NSW, Australia.
Cvetkovski B; Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Glebe, NSW, Australia.
Rimmer J; Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Glebe, NSW, Australia.
Yan K; Macquarie University, Macquarie Park, NSW, Australia.
Cheong L; Macquarie University, Macquarie Park, NSW, Australia.
Bousquet J; Thoracic Medicine, St Vincent's Private Hospital, Darlinghurst, Australia.
Lourenco O; Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Glebe, NSW, Australia.
Bosnic-Anticevich S; Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

Explor Res Clin Soc Pharm ; 12: 100340, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37869069

Palavras-chave

Allergic rhinitis; Community pharmacy; Guideline; Pharmacist; Self-select; Suboptimal management

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Explor Res Clin Soc Pharm Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google